Your browser doesn't support javascript.
loading
The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
Yoldas, Tuba Çelen; Çakar, Nilgün; Basaran, Özge; Acar, Banu; Uncu, Nermin; Çayci, F Semsa.
Afiliación
  • Yoldas TÇ; Department of Pediatrics, Ankara Children's Hematology and Oncology Hospital, Ankara, Turkey.
  • Çakar N; Department of Pediatric Nephrology and Rheumatology, Ankara Children's Hematology and Oncology Hospital, Karapinar mah. 1183. Cadde No: 3/7 Dikmen, Ankara, Turkey.
  • Basaran Ö; Department of Pediatric Nephrology and Rheumatology, Ankara Children's Hematology and Oncology Hospital, Karapinar mah. 1183. Cadde No: 3/7 Dikmen, Ankara, Turkey.
  • Acar B; Department of Pediatric Nephrology and Rheumatology, Ankara Children's Hematology and Oncology Hospital, Karapinar mah. 1183. Cadde No: 3/7 Dikmen, Ankara, Turkey. banuacar@gmail.com.
  • Uncu N; Department of Pediatric Nephrology and Rheumatology, Ankara Children's Hematology and Oncology Hospital, Karapinar mah. 1183. Cadde No: 3/7 Dikmen, Ankara, Turkey.
  • Çayci FS; Department of Pediatric Nephrology and Rheumatology, Ankara Children's Hematology and Oncology Hospital, Karapinar mah. 1183. Cadde No: 3/7 Dikmen, Ankara, Turkey.
Clin Rheumatol ; 35(6): 1603-7, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26384820
This study aimed to investigate the effects of colchicine on growth parameters in familial Mediterranean fever (FMF) patients. Fifty-one (29 girls, 22 boys) FMF patients were enrolled in the study. All of the patients were in the prepubertal stage and had not received colchicine treatment before the study. Anthropometric measurements, demographic features, clinical findings at diagnosis and during periods of attacks of FMF, disease activity, frequency of exacerbations, colchicine dosage, and weight and height measurements were recorded at an interval of 6 months. Height, weight, and body mass index standard deviation scores and Z-scores were calculated. The mean height standard deviation score (HSDS) was significantly increased from -0.64 ± 1.20 to -0.26 ± 1.07 (p < 0.001), the mean weight standard deviation score (WSDS) was significantly increased from -0.60 ± 1.03 to -0.45 ± 0.98 (p = 0.008), and the mean body mass index standard deviation score was decreased from -0.33 ± 1.06 to -0.47 ± 0.98 (p = 0.128) at 1 year after colchicine treatment compared with before initiation of treatment. In patients who had no FMF attacks during colchicine treatment, height and weight were significantly increased at 1 year (HSDS: p < 0.001 WSDS: p = 0.002), but in patients who had recurrent attacks, height and weight did not change (HSDS: p = 0.051, WSDS: p = 0.816). Even when subclinical inflammation is present, preventing attacks of FMF with colchicine allows growth to continue. However, suppression of subclinical inflammation and control of attacks of FMF are required for weight gain.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Mediterránea Familiar / Aumento de Peso / Desarrollo Infantil / Colchicina / Inflamación Tipo de estudio: Observational_studies / Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Clin Rheumatol Año: 2016 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Mediterránea Familiar / Aumento de Peso / Desarrollo Infantil / Colchicina / Inflamación Tipo de estudio: Observational_studies / Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Clin Rheumatol Año: 2016 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania